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Background: Neuroborreliosis represents a relevant infectious disease and can cause a variety of neurological
manifestations. Different stages and syndromes are described and atypical symptoms can result in diagnostic delay
or misdiagnosis. The aim of this retrospective study was to define the pivotal neurological deficits in patients with
neuroborreliosis that were the reason for admission in a hospital.
Methods: We retrospectively evaluated data of patients with neuroborreliosis. Only patients who fulfilled the
diagnostic criteria of an intrathecal antibody production against Borrelia burgdorferi were included in the study.
Results: Sixty-eight patients were identified with neuroborreliosis. Cranial nerve palsy was the most frequent deficit
(50%) which caused admission to a hospital followed by painful radiculitis (25%), encephalitis (12%), myelitis (7%),
and meningitis/headache (6%). In patients with a combination of deficits, back pain was the first symptom,
followed by headache, and finally by cranial nerve palsy. Indeed, signs of meningitis were often found in patients
with neuroborreliosis, but usually did not cause admission to a hospital. Unusual cases included patients with
sudden onset paresis that were initially misdiagnosed as stroke and one patient with acute delirium. Cerebrospinal
fluid (CSF) analysis revealed typical changes including elevated CSF cell count in all but one patient, a blood-CSF
barrier dysfunction (87%), CSF oligoclonal bands (90%), and quantitative intrathecal synthesis of immunoglobulins
(IgM in 74%, IgG in 47%, and IgA in 32% patients). Importantly, 6% of patients did not show Borrelia specific
antibodies in the blood.
Conclusion: In conclusion, the majority of patients presented with typical neurological deficits. However, unusual
cases such as acute delirium indicate that neuroborreliosis has to be considered in a wide spectrum of neurological
diseases. CSF analysis is essential for a reliable diagnosis of neuroborreliosis.Background
Lyme Borreliosis is a tick-borne transmitted infectious
disease caused by the spirochete Borrelia burgdorferi
sensu lato. This spirochete can invade the central ner-
vous systems (CNS) resulting in neuroborreliosis in up
to 15% of the affected patients [1, 2]. The clinical course
of neuroborreliosis is highly variable [3, 4]. Meningoradi-
culitis, also described as Bannwarth’s syndrome, is the
most frequent manifestation of neuroborreliosis in Europe* Correspondence: Skripuletz.Thomas@MH-Hannover.de
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or lancinating pain. Although at least 80% of European
patients present with facial nerve palsy and radiculitis,
symptoms of neuroborreliosis may be quite unspecific
or even mimic other neurological diseases [3, 6]. Myelitis
and encephalitis are rare clinical manifestations [6]. To
date, different stages and syndromes of neuroborreliosis
have been described with up to ten subgroups [4].
The onset of neuroborreliosis is usually subacute with
progression over weeks. However, cases of acute stroke-
like symptoms and chronic encephalitis have also been
described [2, 7]. In clinical practice, patients are usually
categorized into acute neuroborreliosis (symptom durationle is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
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sis (symptom duration > 6 months) [4, 8].
The diagnosis of neuroborreliosis is based on medical
history, clinical findings, serological and cerebrospinal
fluid analysis (CSF) [6, 9]. Detection of pleocytosis,
blood-CSF-barrier dysfunction, intrathecal production of
immunoglobulins (Ig) and especially an intrathecal syn-
thesis of Borrelia specific antibodies in CSF are the best
indicators for definitive diagnosis [10]. Once diagnosed,
the majority of patients with neuroborreliosis experience
a favorable outcome after antibiotic treatment [11–15].
However, in a small number of patients residual symptoms
remain [16].
Here, we performed a thorough evaluation of clinical
and laboratory data in patients with neuroborreliosis.
The aim of this retrospective study was to define pivotal
neurological deficits in patients with neuroborreliosis be-
ing the reason for admission to a hospital.
Methods
Patients
The retrospectively evaluated data originate from 68 pa-
tients. All data were collected for routine diagnostics at
the Hannover Medical School in the time from 1999 to
2014. Only patients who fulfilled the diagnostic criteria
of an intrathecal antibody production against Borrelia
burgdorferi sensu lato were included in the study [8].
The investigation was approved by the institutional ethics
committee.
CSF and serum analytical procedures
CSF and serum were analysed by routine methods [17–19].
CSF cells were counted manually with a Fuchs-Rosenthal
counting chamber. CSF total protein was determined by
the Bradford dye-binding procedure. IgG, IgA, IgM, and al-
bumin were measured in CSF and serum in the same latex
enhanced assay by kinetic nephelometry (Beckman Coulter
IMMAGE). Blood–CSF barrier function was assessed by
CSF-serum albumin quotients (QAlb) [20]. Intrathecal syn-
thesis of IgG, IgA, and IgM was calculated based on the
method of Reiber-Felgenhauer referring the IgG, IgA, and
IgM quotients to the albumin quotient [20]. CSF-specific
oligoclonal bands (OCB) were determined by isoelectric
focusing in polyacrylamide gels with consecutive silver
staining.
IgM and IgG antibody production against Borrelia
burgdorferi sensu lato was determined in serum and
CSF by enzyme-linked immunosorbent assays (ELISA)
according to the instructions of the manufacturer
(recomWell Borrelia® Mikrogen). Western blots (Vir-
aStripe® Viramed) were performed to confirm positive
ELISA results. Intrathecal synthesis of Borrelia burgdorferi
sensu lato specific IgG and IgM antibody specific index
(AI) was calculated according to the formula (CSF IgBorrelia/serum Ig Borrelia)/(CSF Ig total/serum Ig total)
[21]. In case of intrathecal synthesis of immunoglobulins
G and M the following formula was used: (CSF Ig Bor-
relia/serum Ig Borrelia)/Qlim. Qlim represents the Ig
fraction in CSF originating only from blood and was
calculated according to the individual’s albumin quo-
tient [21]. AI values ≥ 1.5 indicate specific antibody
synthesis in the CNS. The AI could be calculated in 62
patients. In 6 patients antibodies against Borrelia
burgdorferi sensu lato were found significantly higher
in CSF than in serum proving an intrathecal synthesis




In the period from 1999 to 2014 a total of 68 patients
were hospitalized with neuroborreliosis. A male pre-
dominance was identified (65%; Table 1). The median
age of all patients at presentation was 45 years. Our co-
hort included 11 children between ages 5 and 14 years.
Immunosuppression as predisposing factor for infectious
diseases was observed in three patients (melanoma,
Crohn’s disease, polyarthritis). Our patients were cate-
gorized into five groups depending on the dominant
neurological deficit that caused admission to our hos-
pital (Table 1): cranial nerve palsy, symptoms/signs of
radiculitis (back pain alone or combined with radiating
pain into the limbs without or with additional limb
palsy), symptoms/signs of meningitis (headache with or
without neck stiffness), symptoms/signs of encephalitis,
and symptoms/signs of myelitis.
Patient’s signs and symptoms
Twenty-three patients (34%) reported previous tick bite
and/or erythema chronicum migrans (Table 1). Nine of
them remembered only tick bite, seven remembered the
occurrence of erythema chronicum migrans with previous
tick bite, while seven remembered erythema chronicum
migrans without previous tick bite.
In the majority (47 patients, 69%), onset of symptoms
occurred between June and September (Fig. 1). 41 pa-
tients (60%) presented between July and September in
our hospital. The median duration from onset of symp-
toms until diagnosis was 16 days (Table 1). A chronic
course of the disease with symptoms persisting for lon-
ger than 6 months was found in 7 patients (10%). Five of
them were diagnosed with chronic encephalitis, one pre-
sented with myelitis and one with radiculitis.
Cranial nerve palsy
Cranial nerve palsy was the most frequent symptom that
led to hospitalization (50%). In this group, 29 patients
(43%) presented with facial nerve palsy and five patients
Table 1 Patient’s characteristics. Age and duration of symptoms to diagnosis are presented by median with lowest and highest
values




All patients 68 45 (5–93) 44/68 23/68 16 (1–733)
Cranial nerve palsy 34 40 (6–77) 23/34 10/34 7 (1–121)
Facial nerve palsy 29 34 (6–77) 16/29 9/29 7 (1–121)
Isolated facial nerve palsy 11 26 (6–73) 7/11 4/11 4 (1–15)
+ Radiculitis 8 57 (18–77) 6/8 2/8 18 (2–49)
+ Meningitis 6 67 (30–93) 4/6 2/6 7 (3–21)
+ Radiculitis + meningitis 4 (34, 43, 44, 57) 3/4 1/4 (2, 21, 28, 121)
Oculomotor nerve palsy 5 53 (38–76) 2/5 1/5 53 (38–76)
Isolated oculomotor nerve palsy 2 (76, 42) 1/2 0/2 (2, 7)
+ Meningitis/Radiculitis 3 (26, 38, 53) 1/3 1/3 (11, 25, 26)
Radiculitis 17 67 (5–93) 10/17 9/17 20 (3–379)
Isolated radiculitis 14 67 (5–93) 8/14 8/14 18 (3–379)
+ Meningitis 3 (13, 65, 75) 2/3 0/3 (3, 22, 30)
Encephalitis 8 70 (8–79) 7/8 2/8 183 (1–732)
Chronic course 5 74 (67–79) 4/5 0/5 186 (81–732)
Acute/Subacute onset 3 (8, 11, 45) 3/3 2/3 (1, 1, 38)
Myelitis 5 37 (7–64) 4/5 0/5 126 (23–733)
Meningitis 4 (22, 34, 45, 64) 0/4 2/4 (1, 4, 7, 120)
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oculomotor nerve palsy (Table 1).
Isolated facial nerve palsy was found in 11 patients
(16%). Except three patients with bilateral facial palsy,
clinical examination could not distinguish these patients
from an idiopathic facial palsy (Bell’s palsy). The other
patients with facial nerve palsy showed a combination
with radiculitis (12%), meningitis/headache (9%), or both
radiculitis and meningitis (6%). Patients with facial nerve
palsy and radiculitis suffered from severe back pain radi-
ating into the limbs and three patients even developed
limb palsy. In all but one of them back pain preceded fa-
cial nerve palsy. In the last patient facial nerve palsy and
limb palsy occurred suddenly.
All patients with facial nerve palsy and meningitis re-
ported headache as the first symptom but facial nerve
palsy was the principal reason for presentation to our
hospital.
The combination of facial nerve palsy, meningitis, and
radiculitis was found in four patients (6%). In all of these
patients back pain was the first symptom, followed by
headache, and finally by facial nerve palsy. One of them
was initially misinterpreted as stroke.
Oculomotor disturbance occurred in five patients. One
patient presented with isolated abducens nerve palsy and
another patient showed isolated oculomotor nerve palsy.
Two patients showed a combination of abducens nervepalsy and meningitis and one presented with abducens
nerve palsy and signs of radiculitis. The latter three
patients suffered from headache or back pain prior to
abducens nerve palsy.
Radiculitis
Symptoms of radiculitis without any affection of cranial
nerves were found in 17 patients (25%). Ten patients
presented with diffuse back pain and four of them reported
radiating pain into the legs and two into the arms. Another
seven patients sustained radiating back pain combined with
unilateral weakness (four with leg palsy, two with arm
palsy). In one patient arm and leg weakness developed sud-
denly, and thus, the patient was initially misinterpreted as
stroke. During the disease course three patients with radiat-
ing back pain developed signs of meningitis.
Encephalitis
Eight patients were classified as having encephalitis
(12%). Three patients presented with symptom duration
of less than 4 weeks and were thus classified as having
acute encephalitis. One patient presented with clinical
signs of delirium for hours. One 8-years old patient was
admitted with four episodes of aphasia and dizziness with
gait disturbance occurring on the day of presentation
without any MRI abnormalities of the brain. One 11-years
old patient reported headache over 3 weeks with ataxia
Fig. 1 Seasonal distribution of patients with neuroborreliosis. Graph
shows onset of symptoms and presentation in our hospital
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fied one T2-lesion in the left basal ganglia and another
one in the left parietal lobe. EEG showed spike wave dis-
charges over left temporo-occipital regions.
Five patients described a slow onset of symptoms with
duration of more than 6 months and were thus classified
as having chronic encephalitis. All these patients were
older than 65 years and revealed cognitive impairment
and gait disorder. MRI of the brain did not show any
signs of inflammation but signs of vascular changes and
brain atrophy.
Myelitis
Five patients presented with signs of myelitis (7%). Para-
spasticity was found in four patients of whom two suf-
fered from weakness in both legs. One patient without
spasticity showed weakness in both arms and reported
transversal impairment of sensation (below T5). Bladder
and rectum function were normal in all patients. Further-
more, these patients did not suffer from cranial nerve palsy
or headache. MRI imaging of the spine confirmed a diagno-
sis of myelitis in all five patients. Lesions were located in
the cervical spinal cord in one patient (C1), in the thoracic
spinal cord in two patients (T1, T7-T12), and crossing the
cervical and thoracic spinal cord in two patients (C7-T1,
C3-T6). In addition, MRI showed an affection of dorsal root
nerves in two patients.
Meningitis
Four patients presented with headache only (6%). During
clinical examination neck stiffness was found in three of
them. Headache was described as diffuse with holoce-
phal localization in three patients and with alternating
localization in one patient. Concomitant fever was found
in only one patient.
Cerebrospinal fluid analyses and antibody response
CSF analysis was performed in all patients (Table 2). All
but one patient showed elevated CSF cell counts. Totalprotein was increased in 58 patients (85%). The albumin
CSF-serum concentration quotient (QAlb) is generally
considered as the best indicator for a blood-CSF barrier
dysfunction [20, 22]. Measurements of QAlb revealed
age-corrected increased values in 59 patients (87%). Bar-
rier impairment was severe in 26 patients (QAlb >20)
and mild to moderate in the others. Only 8 patients pre-
sented CSF lactate concentrations >3.5 mmol/l. 17 pa-
tients showed values within a range of 2.6-3.5 mmol/l,
while the remaining patients presented CSF lactate con-
centrations <2.6 mmol/l.
Oligoclonal bands restricted to the CSF were found in
61 patients (90%) indicating intrathecal IgG synthesis. Five
of these patients showed a combination of oligoclonal
bands restricted to the CSF and identical oligoclonal IgG
bands in CSF and serum (type 3).
Quantitative intrathecal synthesis of immunoglobulins
(Reiber-Felgenhauer graphs) of either IgM, or IgG, or
IgA occurred in 55 patients (81%). Intrathecal synthesis
of IgM was found in 50 patients (74%), IgG synthesis
was found in 32 patients (47%), and IgA synthesis was
found in 22 patients (32%). A combined three-class reac-
tion of intrathecal synthesis of IgG, IgM, and IgA was
found in 16 patients (24%). In addition, two-class reac-
tions with the following combinations were found: IgM
+ IgG in 11 patients (16%), IgM + IgA in three patients
(4%), and IgG + IgA in three patients (4%). Isolated IgM
synthesis was found in 20 patients (29%) and isolated
IgG synthesis was found in two patients (3%). Isolated
IgA synthesis was absent.
When oligoclonal bands were included as a sign of
intrathecal IgG synthesis (qualitative method) a com-
bined three-class reaction of immunoglobulins was then
found in 19 patients (28%). Two-class reactions with the
combinations of IgM + IgG in 31 patients (46%) and IgA
+ IgG in 3 patients (4%) were detected. Isolated IgG syn-
thesis was found in 9 patients (13%). A two-class reac-
tion of IgM + IgA as well as isolated IgM and isolated
IgA synthesis did not occur.
As described above, 55 patients showed quantitative
intrathecal synthesis of immunoglobulins (Reiber-Felgen-
hauer graphs). In this group, 46 patients (84%) showed
highest amounts of IgM synthesis followed by IgA in 5
patients (9%), and IgG in 4 patients (7%).Borrelia burgdorferi sensu lato antibodies
Borrelia burgdorferi sensu lato specific IgG or IgM anti-
bodies, as measured by ELISA, were tested positive in
serum in 64 patients (94%; Fig. 2). In 34 patients both
IgG and IgM positive antibodies were present (50%). 23
patients were positive for IgG but negative for IgM anti-
bodies (34%). Only seven patients were positive for IgM
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specific IgG or IgM antibodies in the serum (6%). By
using immunoblot two of these patients showed negative
serum results as well. The other two patients showed
only one positive band for IgG (VIsE) and one positive
band for IgM (p41 or OspC) in serum. However, in these
four patients CSF analysis revealed pleocytosis (42–738
cells/μl), CSF oligoclonal bands (type 2), and Borrelia
burgdorferi sensu lato specific IgM and IgG in the CSF.
These patients suffered from either meningitis, myelitis,
facial palsy, or a combination of facial palsy, meningitis,
and radiculitis. Symptom duration ranged between 2 days
and 3 weeks.
Figure 2 represents IgG and IgM AI values to Borrelia
burgdorferi sensu lato. CSF results for both IgG and
IgM were available from 52 patients, while in 16 patients
either IgG or IgM were available. In the group of pa-
tients with available data for IgG and IgM, 29 showed
intrathecal synthesis for both IgG and IgM, while in 20
patients intrathecal synthesis was limited to IgG and in
3 patients to IgM only.
Discussion
In this study we classified patients with neuroborreliosis
depending on neurological deficits that were the reason
for presentation in a hospital. Here, we found that signs
of meningitis were often found in patients with neurobor-
reliosis, but usually did not cause admission to a hospital
(Fig. 3). In our cohort, cranial nerve palsy was the most
frequent deficit which caused admission to a hospital
followed by painful radiculitis, encephalitis, myelitis, and
meningitis.
Patients presented either with isolated symptoms/deficits
or a combination of multiple neurological symptoms. In pa-
tients with a combination of deficits, back pain (radiculitis)
was the first symptom, followed by meningitis (headache),
and finally by cranial nerve palsy in all but one patients.
Our results are in line with a previous report showing that
cranial nerve palsy is not the initial symptom when multiple
neurological symptoms are present [23]. The diagnosis of
cranial nerve palsy and myelitis is straightforward for neu-
rologists and lumbar puncture is usually performed. How-
ever, diagnosis of neuroborreliosis can be difficult in other
cases. Patients with radiculitis either reported back pain
only or radiating pain into the limbs with or without
paresis. Pain symptoms were rather unspecific and could
therefore be easily misinterpreted e.g. as herniated disc. In
three patients limb palsy due to radiculitis occurred sud-
denly, which led to initial misdiagnosis stroke.
Encephalitis seems to be another diagnostic challenge
in neuroborreliosis. In our cohort, one patient presented
with severely altered consciousness suggesting delirium
for hours with the need of intensive care. MRI of the
brain showed signs of basal vasculitis without infarction.Stroke on the basis of cerebral vasculitis is indeed a rare
manifestation of neuroborreliosis in both adults and
children and was predominantly described in case re-
ports or series [4, 7, 24–43]. In these cases typical
stroke-like symptoms such as paresis, dysarthria, and/or
aphasia have been reported. Only in few cases paresis
combined with delirium were described. Interestingly, our
patient presented with acute delirium due to vasculitis
without stroke. Since such patients are frequently hospital-
ized in psychiatric institutions, psychiatrists should be
aware of possible neuroborreliosis in patients with acute de-
lirium. Another five patients in our cohort showed symp-
tom duration of more than 6 months and were classified as
chronic encephalitis. These patients were older than
65 years and suffered from cognitive impairment and gait
disorder suspicious for normal pressure hydrocephalus
(NPH). However, lumbar puncture with drainage of CSF
did not change their symptoms. Instead, CSF analysis re-
vealed pleocytosis and intrathecal synthesis of Borrelia spe-
cific antibodies indicating neuroborreliosis. Improvement of
clinical symptoms after antibiotic treatment occurred in all
of these cases. Similar cases of neuroborreliosis with symp-
toms mimicking NPH were already described in some case
reports [44–48]. Pseudotumor cerebri presents another dis-
ease which might be related to neuroborreliosis. In several
reports typical symptoms of pseudotumor cerebri such as
headache and papilledema and an elevated CSF opening
pressure have been described predominantly affecting chil-
dren [49–60]. In these patients antibiotic treatment led to
normalization of symptoms and CSF pressure.
The seasonal distribution of symptom onset might be
of some help in suspicious cases. The majority of our pa-
tients (60%) presented between July and September.
Similar results were communicated in earlier studies in
Danish, Swedish, and Finish populations [6, 23, 61, 62].
Nevertheless, in our cohort neuroborreliosis was diag-
nosed in every month of the year except February.
Therefore, low-risk months are unreliable for ruling out
neuroborreliosis as already suggested [23].
For detection of Borrelia burgdorferi sensu lato infec-
tion serum is usually analyzed using ELISA with subse-
quent confirmation by immunoblot. Remarkably, four of
our patients with neuroborreliosis lacked positive results
for Borrelia infection in the blood (6%) but additional
analysis of the CSF revealed pleocytosis and intrathecal
production of antibodies against Borrelia burgdorferi
sensu lato. Thus, negative blood results do not necessar-
ily rule out neuroborreliosis. The same conclusion was
drawn in previous studies [63–65]. Henningsson and
collegues found Borrelia specific antibodies in the CSF
but not in serum in 25 of 150 patients (17%) by using
ELISA at the time of diagnosis [64].
Our CSF data are largely in line with previous observa-
tions [10, 64, 66, 67]. We found elevated CSF cell counts
Fig. 2 Borrelia burgdorferi sensu lato antibody synthesis in patients with neuroborreliosis. In a serum IgG and IgM antibody results from ELISA
analyses are shown. Serum IgG and IgM values >24U/ml indicate positive results. In b antigen index of Borrelia specific IgG and IgM is shown
which indicates specific intrathecal antibody synthesis. Antigen index values≥ 1.5 indicate an intrathecal synthesis
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curred in 87% patients. Oligoclonal bands restricted to
the CSF were found in 90% patients indicating intra-
thecal IgG synthesis. Quantitatively elevated intrathecal
synthesis of immunoglobulins (either IgM, or IgG, or IgA)
based on the calculation method of Reiber-Felgenhauer
prevailed in 81% of the patients. Intrathecal synthesis of
IgM was found in 74%, IgG synthesis was found in 47%,
and IgA in 32% of the patients. Interestingly, isolated
intrathecal synthesis of IgM or IgA was not found and was
accompanied by positive oligoclonal bands in all cases.
These results demonstrate that neuroborreliosis is accom-
panied by pronounced immunological CSF changes.
Active neuroborreliosis without pleocytosis is contro-
versially discussed and three scenarios are suggestedFig. 3 Distribution of neurological symptoms/diagnoses in patients with ne
reason for presentation in our hospital. In fact, some patients showed more
occur at the same time and back pain (radiculitis) was usually the first sym
palsy. In b the distribution of all symptoms is shown. This reveals that sign
as indicated in A, usually did not cause admission to a hospital[3, 64, 66, 68]. The most common interpretation is that
the majority of cases with intrathecal Borrelia specific anti-
body production without CSF pleocytosis are due to a pre-
vious neuroborreliosis. However, other authors attribute
the absence of pleocytosis in some cases to a prolonged
disease. Henningsson and colleagues described four cases
with normal CSF cell count and a long history of illness
(from 36 weeks till 6 years) [64]. Remarkably these four
patients displayed the highest Borrelia specific IgG indices
in their cohort and they have speculated that the initial
pleocytosis might have been already resolved by the time
of lumbar puncture probably reflecting the natural course
of the disease. Conversely, others suggested that the lack
of elevated CSF cell count may be associated with the
brevity in disease duration in some cases. Rupprecht anduroborreliosis. In a the pivotal symptoms are shown that were the
than one neurological symptom. In these patients symptoms did not
ptom, followed by meningitis (headache), and finally by cranial nerve
s of meningitis were often found in patients with neuroborreliosis, but,
Schwenkenbecher et al. BMC Infectious Diseases  (2017) 17:90 Page 8 of 10colleagues described two cases with normal cell counts
who were successfully treated with antibiotics [68]. Re-
peated CSF analyses after 6 or 14 days indeed discovered
an increase in cell counts and an elevation of the Borrelia
specific antibody index confirming active neuroborreliosis.
Our cohort included only one patient without pleocytosis
whose symptoms resolved completely after treatment with
ceftriaxone. However, this patient did not undergo a sec-
ond lumbar puncture, and thus, according to the diagnos-
tic criteria there is a limitation regarding a definitive
diagnosis. In our opinion, antibiotic treatment in such
cases is justified with the important restriction that such a
therapy has not been conducted before. The chemokine
CXCL13 has been evaluated as a possible CSF biomarker
for detection of acute neuroborreliosis [69–71]. CXCL13
analysis might help in such cases to differentiate between
acute neuroborreliosis and previous infection. However,
CXCL13 is not yet in use as a routine parameter due to
concerns about the specificity [68].
Conclusions
This study shows that most, but not all patients with
neuroborreliosis presented with typical neurological
findings and consistent CSF changes. Uncommon pre-
sentations such as acute delirium and stroke-like symp-
toms underline the variety of symptoms. A thorough
CSF analysis is considered essential for a reliable diagno-
sis of neuroborreliosis.
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